Decreased expression of p27 is associated with malignant transformation and extrathyroidal extension in papillary thyroid carcinoma

被引:4
作者
Do, Sung-Im [1 ]
Kim, Dong Hyun [1 ]
Yang, Jung-Ho [1 ]
Pyo, Jung-Soo [1 ]
Kim, Kyungeun [1 ]
Lee, Hyunjoo [1 ]
Do, In-Gu [1 ]
Kim, Dong-Hoon [1 ]
Chae, Seoung Wan [1 ]
Sohn, Jin Hee [1 ]
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Pathol, 29 Saemunan Ro, Seoul 110746, South Korea
关键词
Papillary thyroid carcinoma; p16; p27; p53; Extrathyroidal extension; P53 PROTEIN EXPRESSION; PROGNOSTIC-FACTORS; TUMOR-ANTIGEN; UNITED-STATES; LYMPH-NODE; CELL-CYCLE; METASTASIS; P16; P16(INK4A); CANCER;
D O I
10.1007/s13277-015-4163-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cell cycle regulatory proteins including p16, p27, and p53 are well studied in various cancers. However, their single or concurrent roles related with the clinicopathological parameters are not clearly recognized. We analyzed the expression of p16, p27, and p53 cell cycle regulatory proteins in papillary thyroid carcinoma (PTC). To determine the prognostic significance of cell cycle regulatory proteins, 107 PTCs were examined. We analyzed the individual expression of p16, p27, and p53 and their concurrent expressions, with the relationship to various clinicopathological parameters including differentiation from benign lesions. High expression of p16 and p53 and low expression of p27 were related with the distinguishing of PTC from benign lesions. In addition, normal thyroidal tissue showed higher p27 expression than nodular hyperplasia. In relation to extrathyroidal extension (ETE), the low expression of p27 was related with the presence of ETE. The low expression of p27 and high expression of p16 and p53 may affect the development of PTC. In addition, low p27 expression is related with the existence of ETE.
引用
收藏
页码:3359 / 3364
页数:6
相关论文
共 37 条
  • [1] Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer
    Bai, Jin
    Zhou, Yan
    Chen, Guangdi
    Zeng, Jinyan
    Ding, Jingjing
    Tan, Yongfei
    Zhou, Jianwei
    Li, Gang
    [J]. HUMAN PATHOLOGY, 2011, 42 (03) : 375 - 383
  • [2] Bai L, 2006, P53 STRUCTURE FUNCTI
  • [3] An immunohistochemical study of p16INK4a expression in multistep thyroid tumourigenesis
    Ball, Elizabeth
    Bond, Jane
    Franc, Brigitte
    DeMicco, Catherine
    Wynford-Thomas, David
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (01) : 194 - 201
  • [4] DNA Hypermethylation of Cell Cycle (p15 and p16) and Apoptotic (p14, p53, DAPK and TMS1) Genes in Peripheral Blood of Leukemia Patients
    Bodoor, Khaldon
    Haddad, Yazan
    Alkhateeb, Asem
    Al-Abbadi, Abdullah
    Dowairi, Mohammad
    Magableh, Ahmad
    Bsoul, Nazzal
    Ghabkari, Abdulhameed
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (01) : 75 - 84
  • [5] Hypermethylation of the CDKN2/pl6INK4A promotor in thyroid carcinogenesis
    Boltze, C
    Zack, S
    Quednow, C
    Bettge, S
    Roessner, A
    Schneider-Stock, R
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (06) : 399 - 404
  • [6] CIECHANOVER A, 1994, J BIOL CHEM, V269, P9582
  • [7] THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY
    CIECHANOVER, A
    [J]. CELL, 1994, 79 (01) : 13 - 21
  • [8] Increasing incidence of thyroid cancer in the United States, 1973-2002
    Davies, L
    Welch, HG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (18): : 2164 - 2167
  • [9] OVEREXPRESSION OF P53 AS A POSSIBLE PROGNOSTIC FACTOR IN HUMAN THYROID-CARCINOMA
    DOBASHI, Y
    SAKAMOTO, A
    SUGIMURA, H
    MERNYEI, M
    MORI, M
    OYAMA, T
    MACHINAMI, R
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (04) : 375 - 381
  • [10] Demystified ... -: Cell cycle
    Gillett, CE
    Barnes, DM
    [J]. JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1998, 51 (06): : 310 - 316